Despite several basic studies on the pharmacological functions of some selective CB1/CB2 receptor agonists and/or antagonists on experimental models of kidney disease, there are few reports indicating the effects of CBD on acute and chronic kidney disease. Here, CNR1 is linked to kidney disorder.